ezogabine has been researched along with 2,5-dimethylcelecoxib in 2 studies
Studies (ezogabine) | Trials (ezogabine) | Recent Studies (post-2010) (ezogabine) | Studies (2,5-dimethylcelecoxib) | Trials (2,5-dimethylcelecoxib) | Recent Studies (post-2010) (2,5-dimethylcelecoxib) |
---|---|---|---|---|---|
383 | 26 | 241 | 42 | 0 | 28 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, HL; Du, XN; Fu, Y; Gao, HX; Gao, ZB; Li, JW; Qi, JL; Wan, YM; Zhan, Y; Zhang, HL; Zhang, X | 1 |
Brueggemann, LI; Byron, KL; Cribbs, LL; Haick, JM; Neuburg, S; Randhawa, D; Tate, S | 1 |
2 other study(ies) available for ezogabine and 2,5-dimethylcelecoxib
Article | Year |
---|---|
Characteristics and molecular basis of celecoxib modulation on K(v)7 potassium channels.
Topics: Animals; Carbamates; Celecoxib; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; HEK293 Cells; Humans; KCNQ Potassium Channels; Neurons; Phenylenediamines; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Superior Cervical Ganglion; Transfection | 2011 |
KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Topics: Acetylcholine; Adrenergic beta-2 Receptor Agonists; Animals; Anthracenes; Asthma; Bronchi; Bronchoconstriction; Bronchoconstrictor Agents; Bronchodilator Agents; Carbamates; Ethanolamines; Formoterol Fumarate; KCNQ Potassium Channels; Keratolytic Agents; Male; Membrane Transport Modulators; Methacholine Chloride; Myocytes, Smooth Muscle; Organometallic Compounds; Patch-Clamp Techniques; Phenylenediamines; Potassium Channel Blockers; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Sulfonamides | 2014 |